OP82 – Peptide Receptor Radionuclide Therapy retreatment with 177Lu-dotatate in well differentiated G1/G2 Gastro-EnteroPancreatic neuroendocrine tumors after a previous 90Y- dotatoc treatment: toxicity and activity evaluation

Presentazione non disponibile